SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-4
acquisitionAnnounced · Jan 19, 2026biopharmaSource · SpeculativeArticle · Factual
Sun Pharma acquires Organon
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Full Acquisition
Status
Pending
Sun Pharma agreed to acquire Organon. Reported deal value: Undisclosed. Status: Pending. Sector: biopharma. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.
Sun Pharmaceutical Industries Ltd submitted a non- binding offer to acquire US-headquartered Organon on Thursday, said people in the know, pushing ahead with its boldest global bet ever
Deal timeline
Announced
Jan 19, 2026 · economictimes.indiatimes.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharma. Figures and status may change as sources update.
Sources: economictimes.indiatimes.com · Primary article · FireStrike proprietary index